Insmed, Inc. (INSM)
159.03
-5.88
(-3.57%)
USD |
NASDAQ |
Feb 23, 16:00
158.12
-0.91
(-0.57%)
Pre-Market: 08:39
Insmed Research and Development Expense (Quarterly) : 254.91M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Biogen, Inc. | 434.00M |
| Mirum Pharmaceuticals, Inc. | 42.90M |
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| CorMedix, Inc. | 5.098M |